Collecting and Storing Malignant, Borderline Malignant Neoplasms, and Related Samples From Young Patients With Cancer
- Conditions
- Hairy Cell LeukemiaSecondary Acute Myeloid LeukemiaAtypical Chronic Myeloid Leukemia, BCR-ABL1 NegativeNeoplasm of Uncertain Malignant PotentialChronic Lymphocytic LeukemiaAcute Undifferentiated LeukemiaChildhood Acute Lymphoblastic LeukemiaChildhood Acute Myeloid LeukemiaChildhood Solid NeoplasmJuvenile Myelomonocytic Leukemia
- Interventions
- First Posted Date
- 2009-05-12
- Last Posted Date
- 2018-07-19
- Lead Sponsor
- Children's Oncology Group
- Target Recruit Count
- 2545
- Registration Number
- NCT00898079
- Locations
- 🇺🇸
Arkansas Children's Hospital, Little Rock, Arkansas, United States
🇺🇸MedStar Georgetown University Hospital, Washington, District of Columbia, United States
🇺🇸University of Mississippi Medical Center, Jackson, Mississippi, United States
Gene Expression Profiles to Categorize Wilms Tumors
- First Posted Date
- 2009-05-12
- Last Posted Date
- 2016-05-19
- Lead Sponsor
- Children's Oncology Group
- Target Recruit Count
- 600
- Registration Number
- NCT00897637
- Locations
- 🇺🇸
Saint Mary's Hospital, West Palm Beach, Florida, United States
🇺🇸Children's Oncology Group, Arcadia, California, United States
Identifying Risk Factors for Bone Tissue Death in Young Patients With Acute Lymphoblastic Leukemia Treated on Clinical Trial CCG-1882
- Conditions
- First Posted Date
- 2009-05-12
- Last Posted Date
- 2016-05-11
- Lead Sponsor
- Children's Oncology Group
- Target Recruit Count
- 671
- Registration Number
- NCT00898469
DNA Analysis of Tumor Tissue Samples From Young Patients With Acute Lymphoblastic Leukemia
- First Posted Date
- 2009-05-12
- Last Posted Date
- 2022-08-15
- Lead Sponsor
- Children's Oncology Group
- Target Recruit Count
- 520
- Registration Number
- NCT00897507
- Locations
- 🇺🇸
Childrens Oncology Group, Philadelphia, Pennsylvania, United States
Decision Making About Participating in Pharmacokinetic Studies in Patients Enrolled in a Phase I Treatment Clinical Trial
- First Posted Date
- 2009-04-29
- Last Posted Date
- 2015-10-21
- Lead Sponsor
- Children's Oncology Group
- Target Recruit Count
- 53
- Registration Number
- NCT00890435
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Promyelocytic Leukemia
- First Posted Date
- 2009-03-23
- Last Posted Date
- 2022-10-25
- Lead Sponsor
- Children's Oncology Group
- Target Recruit Count
- 106
- Registration Number
- NCT00866918
- Locations
- 🇺🇸
Overlook Hospital, Summit, New Jersey, United States
🇺🇸Rutgers Cancer Institute of New Jersey-Robert Wood Johnson University Hospital, New Brunswick, New Jersey, United States
🇺🇸Valley Children's Hospital, Madera, California, United States
Pegaspargase and Combination Chemotherapy in Treating Younger Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia (Closed to Accrual 4-22-2011)
- Conditions
- Interventions
- Drug: CyclophosphamideDrug: CytarabineDrug: Daunorubicin HydrochlorideDrug: DexamethasoneDrug: Doxorubicin HydrochlorideOther: Laboratory Biomarker AnalysisDrug: MercaptopurineDrug: MethotrexateDrug: PegaspargaseDrug: ThioguanineDrug: Vincristine SulfateDrug: PrednisoneRadiation: Prophylactic Cranial Irradiation
- First Posted Date
- 2009-03-20
- Last Posted Date
- 2021-04-27
- Lead Sponsor
- Children's Oncology Group
- Target Recruit Count
- 104
- Registration Number
- NCT00866307
- Locations
- 🇺🇸
Children's Hospital Los Angeles, Los Angeles, California, United States
🇺🇸Saint Vincent Hospital and Health Care Center, Indianapolis, Indiana, United States
🇺🇸Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center, Houston, Texas, United States
Neuropsychological and Behavioral Testing in Younger Patients With Cancer
- Conditions
- Interventions
- First Posted Date
- 2008-10-15
- Last Posted Date
- 2024-08-26
- Lead Sponsor
- Children's Oncology Group
- Target Recruit Count
- 1200
- Registration Number
- NCT00772200
- Locations
- 🇺🇸
University of Illinois, Chicago, Illinois, United States
🇺🇸Blank Children's Hospital, Des Moines, Iowa, United States
🇺🇸Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center, Houston, Texas, United States
Zoledronic Acid and Combination Chemotherapy in Treating Patients With Newly Diagnosed Metastatic Osteosarcoma
- Conditions
- Interventions
- Drug: cisplatinDrug: dexrazoxane hydrochlorideDrug: doxorubicin hydrochlorideDrug: etoposideDrug: ifosfamideDrug: leucovorin calciumDrug: methotrexateDrug: zoledronic acidProcedure: adjuvant therapyProcedure: neoadjuvant therapyProcedure: therapeutic conventional surgeryBiological: filgrastimDrug: Mesna
- First Posted Date
- 2008-08-28
- Last Posted Date
- 2014-07-04
- Lead Sponsor
- Children's Oncology Group
- Target Recruit Count
- 24
- Registration Number
- NCT00742924
- Locations
- 🇺🇸
Childrens Hospital Los Angeles, Los Angeles, California, United States
🇺🇸AFLAC Cancer Center and Blood Disorders Service of Children's Healthcare of Atlanta - Egleston Campus, Atlanta, Georgia, United States
🇺🇸Maine Children's Cancer Program at Barbara Bush Children's Hospital, Scarborough, Maine, United States
Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies
- First Posted Date
- 2008-08-18
- Last Posted Date
- 2024-04-11
- Lead Sponsor
- Children's Oncology Group
- Target Recruit Count
- 5000
- Registration Number
- NCT00736749
- Locations
- 🇺🇸
University of Illinois, Chicago, Illinois, United States
🇺🇸Valley Children's Hospital, Madera, California, United States
🇺🇸Riley Hospital for Children, Indianapolis, Indiana, United States